NewsCase
.com
Financial Intelligence
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
🌐
EN
中文
Menu
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
Search NewsCase
Home
Pharma & Biotech
Pharma & Biotech
AI & Quantum Computing
Analysis
Anime
Asian Markets
Automotive & E-Mobility
Banking & Insurance
Bitcoin
Blockchain
Bonds
Ocugen Rewrites Phase 3 Yardstick as Cash Questions Loom Over 2027 Readout
Analysis
October 20, 2026
Moderna’s Friday Slide Says More About Positioning Than About Science
Analysis
October 18, 2026
Ocugen’s 2027 BLA Target Confirmed as Shareholders Face a Long Wait and a Dilution Vote
Analysis
October 18, 2026
BioNTech’s BNT113 Misses Progression-Free Survival Goal, but AHEAD-MERIT Trial Soldiers On
Analysis
October 17, 2026
Ocugen’s 250-Million-Share Request Puts the 2027 Data Gap in Sharp Relief
Analysis
October 17, 2026
Moderna’s Split Screen: Index Demand and Analyst Doubts Collide Ahead of Two Autumn Catalysts
Analysis
October 16, 2026
Moderna’s Next Real Test: Two Dates in Late 2026, Not the Index Seat It Already Has
Analysis
October 15, 2026
BioNTech’s AHEAD-MERIT Setback and Insider Sales Test Investor Patience
Analysis
October 15, 2026
1
2
3
4
...
106
Page 3 of 106